JP2006273834A5 - - Google Patents

Download PDF

Info

Publication number
JP2006273834A5
JP2006273834A5 JP2005178874A JP2005178874A JP2006273834A5 JP 2006273834 A5 JP2006273834 A5 JP 2006273834A5 JP 2005178874 A JP2005178874 A JP 2005178874A JP 2005178874 A JP2005178874 A JP 2005178874A JP 2006273834 A5 JP2006273834 A5 JP 2006273834A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005178874A
Other languages
Japanese (ja)
Other versions
JP2006273834A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2005178874A priority Critical patent/JP2006273834A/en
Priority claimed from JP2005178874A external-priority patent/JP2006273834A/en
Publication of JP2006273834A publication Critical patent/JP2006273834A/en
Publication of JP2006273834A5 publication Critical patent/JP2006273834A5/ja
Pending legal-status Critical Current

Links

Description

JP2005178874A 2004-06-28 2005-06-20 Ampk activator Pending JP2006273834A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005178874A JP2006273834A (en) 2004-06-28 2005-06-20 Ampk activator

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004189150 2004-06-28
JP2005059874 2005-03-04
JP2005178874A JP2006273834A (en) 2004-06-28 2005-06-20 Ampk activator

Publications (2)

Publication Number Publication Date
JP2006273834A JP2006273834A (en) 2006-10-12
JP2006273834A5 true JP2006273834A5 (en) 2007-03-22

Family

ID=37208915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005178874A Pending JP2006273834A (en) 2004-06-28 2005-06-20 Ampk activator

Country Status (1)

Country Link
JP (1) JP2006273834A (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070244202A1 (en) * 2004-06-28 2007-10-18 Kao Corporation Ampk Activator
KR20110039348A (en) * 2008-08-06 2011-04-15 노보 노르디스크 헬스 케어 악티엔게젤샤프트 Conjugated proteins with prolonged in vivo efficacy
JP5594819B2 (en) * 2009-12-22 2014-09-24 キリンホールディングス株式会社 Composition for improving lipid metabolism
JP5753542B2 (en) * 2009-12-29 2015-07-22 コリア インスティチュート オブ オリエンタル メディシン Composition and functional food for obesity treatment and prevention using tiger cane butanol fraction or ethyl acetate fraction
JP5848042B2 (en) 2011-06-29 2016-01-27 株式会社ロッテ Eye fatigue inhibiting composition and food and drink containing the same
WO2013051459A1 (en) * 2011-10-02 2013-04-11 キユーピー 株式会社 Promoter capable of promoting inhibition of expression of mrna by rna interference, and use thereof
JP5895479B2 (en) * 2011-11-30 2016-03-30 ユーハ味覚糖株式会社 AMP-activated protein kinase activator
JP5953745B2 (en) * 2011-12-28 2016-07-20 ユーハ味覚糖株式会社 Sugar absorption inhibitor
JP2014070071A (en) * 2012-09-28 2014-04-21 Kaoru Inagami Material containing of 3,5,4'-trihydroxy-trans-stilbene
US10155003B2 (en) * 2014-05-05 2018-12-18 The Board Of Regents Of The University Of Texas System Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
US10285963B2 (en) * 2015-06-08 2019-05-14 Horacio Astudillo de la Vega Combination of metabolic bio-energetic and nutra-epigentic regulators, nutraceutical compounds in conventional and nanotechnologies combination to revert and prevent the chronic damage accelerated cellular senescence produced by diabetes and other degenerative chronic complex diseases
EP3791871A4 (en) * 2018-10-04 2021-06-23 Hosoda Shc Co., Ltd. Composition for improving intestinal flora

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001072583A (en) * 1999-09-07 2001-03-21 Sunstar Inc Prophylactic or therapeutic composition for hyperlipemia
US7384920B2 (en) * 2001-07-26 2008-06-10 Institute Of Radiation Medicine, Academy Of Military Medical Sciences, Pla Use of stilbene compounds in the manufacture of medicament for the prevention and treatment of diabetes or retrovirus-associated diseases
US7119110B2 (en) * 2001-10-05 2006-10-10 Interhealth Nutraceuticals Incorporated Method and composition for preventing or reducing the symptoms of insulin resistance syndrome

Similar Documents

Publication Publication Date Title
JP2008512492A5 (en)
JP2006257115A5 (en)
JP2008512398A5 (en)
JP2008512356A5 (en)
JP2007516202A5 (en)
JP2006045672A5 (en)
JP2006063441A5 (en)
JP2005261231A5 (en)
JP2007514712A5 (en)
JP2007119645A5 (en)
JP2008525570A5 (en)
JP2007231207A5 (en)
JP2007321035A5 (en)
JP2008524415A5 (en)
JP2006273834A5 (en)
JP2007190226A5 (en)
JP2008525527A5 (en)
JP2007001784A5 (en)
JP2005120465A5 (en)
JP2007153801A5 (en)
JP2007254440A5 (en)
JP2005095148A5 (en)
JP2007537849A5 (en)
JP2006289212A5 (en)
JP2007526266A5 (en)